Jul 12, 2021 | Letters Supported
Patient groups, advocates, and providers have seen disturbing media reports about Cigna’s recent letter to patients and providers regarding the use of Cosentyx. In the letter, patients are encouraged to switch to a Cigna-preferred drug, as Cosentyx was removed from...
Read more
May 14, 2021 | Letters Supported
We, the undersigned, want to express our support for S0859, a much-needed bill that will protect patient access to co-pay assistance programs many Rhode Islanders depend on to cover significant portions of prescription medicine co-pays. We thank you for co-sponsoring...
Read more
May 4, 2021 | Letters Supported
The undersigned organizations are writing, in anticipation of the reintroduction of the Elijah E. Cummings Lower Drug Costs Now Act (i.e., H.R. 3), to urge Congress to keep any international reference pricing proposals (including “International Pricing...
Read more
May 4, 2021 | Letters Supported
Patient groups, advocates, and providers have seen disturbing media reports about Cigna’s recent letter to patients and providers regarding the use of Cosentyx. In the letter, patients are encouraged to switch to a Cigna-preferred drug, as Cosentyx was removed from...
Read more
Mar 29, 2021 | Access, Federal Issues, Letters Supported
On behalf of the undersigned organizations representing diverse patient and provider stakeholders who are concerned with the effects of rebate walls on patient treatment access, we greatly appreciate your leadership on critical efforts to protect patient well-being....
Read more
Mar 18, 2021 | Copay Accumulators, Letters Supported
New York has a strong record in leading the nation in providing access to affordable health coverage. Despite the strides the state has made in expanding coverage, many New Yorkers still face hardship when faced with prescription drug costs. New Yorkers and others...
Read more
